Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype
A PI3Kα-selective inhibitor has recently been approved for use in breast tumors harboring mutations in PIK3CA, the gene encoding p110α. Preclinical studies have suggested that the PI3K/AKT/mTOR signaling pathway influences stemness, a dedifferentiation-related cellular phenotype associated with aggr...
Enregistré dans:
Auteurs principaux: | Ralitsa R. Madsen, Emily C. Erickson, Oscar M. Rueda, Xavier Robin, Carlos Caldas, Alex Toker, Robert K. Semple, Bart Vanhaesebroeck |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f2d3dd26e39c4ceca26dce8f4f8da04b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype.
par: Ralitsa R Madsen, et autres
Publié: (2021) -
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
par: Eun Jin Sun, et autres
Publié: (2021) -
Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells
par: Yumi Fujimoto, et autres
Publié: (2020) -
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
par: R. Reilly, et autres
Publié: (2017) -
The importance of the PI3K/AKT/mTOR signaling pathway in canine neoplasms: Literature review
par: Ferreira,MGPA, et autres
Publié: (2016)